Ocrelizumab and obliterative bronchiolitis Patient Reports February 07, 2012

Ocrelizumab Side Effects Report #5507151-9
Ocrelizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 24, 2007. Male patient, weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Ocrelizumab. After drug was administered, patient experienced the following side effects: obliterative bronchiolitis, pulmonary embolism . Ocrelizumab dosage: 200 MG/M2, Q3W. During the same period patient was treated with MABTHERA, ALLOPURINOL, CHLORAMBUCIL, FLUDARABINE PHOSPHATE. Patient was hospitalized and became disabled. Patient died on 05/25/2006.